Genome-wide analysis of triple-negative phenotype breast tumors
Автор: Ibragimova M.K., Tsyganov M.M., Litvyakov N.V.
Журнал: Cardiometry @cardiometry
Статья в выпуске: 24, 2022 года.
Бесплатный доступ
Introduction. Identification of the molecular genetic phenotype of breast carcinomas is an important prognostic factor of the disease, and helps to personalize the treatment of such patients. According to the evidence data from the reference literature, breast cancer (BC) with a triple negative phenotype among all molecular subtypes accounts for about 10-24%, showing the most aggressive progression and, as a result, has the worst prognosis.
Короткий адрес: https://sciup.org/148326324
IDR: 148326324 | DOI: 10.18137/cardiometry.2022.24.conf.31
Список литературы Genome-wide analysis of triple-negative phenotype breast tumors
- Derakhshan F, Reis-Filho JS. Pathogenesis of Triple-Negative Breast Cancer. Annual Review of Pathology: Mechanisms of Disease. 2022; 17(1):181-204. 10.1146/annurev-pathol-042420- 093238.
- Lee K-L, Kuo Y-C, Ho Y-S, Huang Y-H. Triple-Negative Breast Cancer: Current Understanding and Future Therapeutic Breakthrough Targeting Cancer Stemness. Cancers. 2019; 11(9): 1334. -.
- Mersin H, Yildirim E, Berberoglu U, et al. The prognostic importance of triple negative Breast carcinoma. Breast. 2008; 17:341-346.
- Qiu J, Xue X, Hu C, et al. Comparison of clinicopathological features and prognosis in triplenegative and non-triple negative breast cancer. J Cancer. 2016; 7(2): 167-173.
- Yang C-Q, Liu J, Zhao S-Q, et al. Recent treatment progress of triple negative breast cancer. Progress in Biophysics and Molecular Biology 2020; 151:40-53.
Статья
